1. Home
  2. SNGX vs YAAS Comparison

SNGX vs YAAS Comparison

Compare SNGX & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • YAAS
  • Stock Information
  • Founded
  • SNGX 1987
  • YAAS 2018
  • Country
  • SNGX United States
  • YAAS China
  • Employees
  • SNGX N/A
  • YAAS N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • YAAS Computer Software: Prepackaged Software
  • Sector
  • SNGX Health Care
  • YAAS Technology
  • Exchange
  • SNGX Nasdaq
  • YAAS Nasdaq
  • Market Cap
  • SNGX 10.1M
  • YAAS 9.5M
  • IPO Year
  • SNGX 1987
  • YAAS 2024
  • Fundamental
  • Price
  • SNGX $2.92
  • YAAS $0.08
  • Analyst Decision
  • SNGX Strong Buy
  • YAAS
  • Analyst Count
  • SNGX 1
  • YAAS 0
  • Target Price
  • SNGX $6.00
  • YAAS N/A
  • AVG Volume (30 Days)
  • SNGX 10.0M
  • YAAS 20.5M
  • Earning Date
  • SNGX 11-07-2025
  • YAAS 07-14-2025
  • Dividend Yield
  • SNGX N/A
  • YAAS N/A
  • EPS Growth
  • SNGX N/A
  • YAAS N/A
  • EPS
  • SNGX N/A
  • YAAS N/A
  • Revenue
  • SNGX N/A
  • YAAS $581,862.00
  • Revenue This Year
  • SNGX N/A
  • YAAS N/A
  • Revenue Next Year
  • SNGX N/A
  • YAAS N/A
  • P/E Ratio
  • SNGX N/A
  • YAAS N/A
  • Revenue Growth
  • SNGX N/A
  • YAAS N/A
  • 52 Week Low
  • SNGX $1.09
  • YAAS $0.06
  • 52 Week High
  • SNGX $6.23
  • YAAS $7.00
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 51.64
  • YAAS 25.86
  • Support Level
  • SNGX $2.58
  • YAAS $0.07
  • Resistance Level
  • SNGX $3.11
  • YAAS $0.09
  • Average True Range (ATR)
  • SNGX 0.22
  • YAAS 0.02
  • MACD
  • SNGX -0.09
  • YAAS -0.00
  • Stochastic Oscillator
  • SNGX 43.59
  • YAAS 5.81

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: